These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 4119680

  • 1. Displacement of sulfonylureas from human serum proteins by coumarin derivatives and cortical steroids.
    Judis J.
    J Pharm Sci; 1973 Feb; 62(2):232-7. PubMed ID: 4119680
    [No Abstract] [Full Text] [Related]

  • 2. Binding of sulfonylureas to serum albumin.
    Crooks MJ, Brown KF.
    J Pharm Sci; 1973 Nov; 62(11):1904-6. PubMed ID: 4758102
    [No Abstract] [Full Text] [Related]

  • 3. Binding of sulfonylureas to serum proteins.
    Judis J.
    J Pharm Sci; 1972 Jan; 61(1):89-93. PubMed ID: 5058652
    [No Abstract] [Full Text] [Related]

  • 4. The pharmacology of sulfonylureas.
    Skillman TG, Feldman JM.
    Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
    [Abstract] [Full Text] [Related]

  • 5. Interactions of sulfonylureas with plasma proteins.
    Hsu PL, Ma JK, Luzzi LA.
    J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196
    [No Abstract] [Full Text] [Related]

  • 6. [Protein binding of glisoxepide and its influence on the protein binding of phenprocoumon].
    Schlossmann K.
    Arzneimittelforschung; 1974 Mar; 24(0):392-7. PubMed ID: 4408096
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic effects of hypoglycemic sulfonylureas. V. In vitro effects of sulfonylureas on mitochondrial adenosine triphosphatase activity.
    Debeer L, Mannaerts G, De Schepper PJ.
    Biochem Pharmacol; 1974 Jan 15; 23(2):251-8. PubMed ID: 4273213
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.
    Joseph KS, Hage DS.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun 01; 878(19):1590-8. PubMed ID: 20435530
    [Abstract] [Full Text] [Related]

  • 9. [Oral antidiabetics. Dose, plasma concentration and effect].
    Ariëns EJ.
    Acta Diabetol Lat; 1969 Sep 01; 6 Suppl 1():143-76. PubMed ID: 4392071
    [No Abstract] [Full Text] [Related]

  • 10. Nuclear magnetic resonance study of the binding of tolbutamide and chlorpropamide to bovine serum albumin.
    Ueda H, Higashiyama K, Nagai T.
    Chem Pharm Bull (Tokyo); 1980 Sep 01; 28(4):1016-21. PubMed ID: 7418103
    [No Abstract] [Full Text] [Related]

  • 11. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
    SMITH DL, VECCHIO TJ, FORIST AA.
    Metabolism; 1965 Mar 01; 14():229-40. PubMed ID: 14261407
    [No Abstract] [Full Text] [Related]

  • 12. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T, Nakamura K, Furukawa H, Watanabe M, Kuwashima J, Miyazaki H, Kawashima K, Kuzuya T.
    Arzneimittelforschung; 1983 Mar 01; 33(11):1535-7. PubMed ID: 6686448
    [Abstract] [Full Text] [Related]

  • 13. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L, Kristensen M, Hansen M, Siersbaek-Nielsen K.
    Acta Med Scand; 1976 Mar 01; 199(6):513-5. PubMed ID: 59517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Binding of sulfonylurea derivatives to bovine serum albumin: part I. Binding of SPC--703, tolbutamide, glibornuride and glipizide.
    Wójcikowski C, Szlabowicz D.
    Pol J Pharmacol Pharm; 1977 Mar 01; 29(5):469-75. PubMed ID: 22846
    [No Abstract] [Full Text] [Related]

  • 16. Binding of sulfonylureas to serum albumin: a response.
    Judis J.
    J Pharm Sci; 1973 Nov 01; 62(11):1906-7. PubMed ID: 4758103
    [No Abstract] [Full Text] [Related]

  • 17. Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylureas.
    Tsuchiya S, Sakurai T, Sekiguchi S.
    Biochem Pharmacol; 1984 Oct 01; 33(19):2967-71. PubMed ID: 6487349
    [Abstract] [Full Text] [Related]

  • 18. Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection.
    Braselton WE, Bransome ED, Huff TA.
    Diabetes; 1977 Jan 01; 26(1):50-7. PubMed ID: 830565
    [Abstract] [Full Text] [Related]

  • 19. An electrophoretic investigation of the binding of 3-14C coumarin to rat serum proteins.
    Piller NB, Schmitt LH.
    Experientia; 1977 Aug 15; 33(8):1072-4. PubMed ID: 70376
    [Abstract] [Full Text] [Related]

  • 20. SERUM CONCENTRATION AND URINARY EXCRETION OF ORAL SULFONYLUREA COMPOUNDS: RELATION TO DIABETIC CONTROL.
    SHELDON J, ANDERSON J, STONER L.
    Diabetes; 1965 Jun 15; 14():362-7. PubMed ID: 14298920
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.